Cargando…

SARS-COV-2 Vaccines: What Indicators are Associated with the Worldwide Distribution of the First Doses

The present study aimed to identify the factors associated with the distribution of the first doses of the COVID-19 vaccine. In this study, we used 9 variables: human development index (HDI), gross domestic product (GDP per capita), Gini index, population density, extreme poverty, life expectancy, C...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobral, Marcos Felipe Falcão, Bezerra de Oliveira, Brigitte Renata, Gomes da Penha Sobral, Ana Iza, Monteiro Marinho, Marcelo Luiz, Duarte, Gisleia Benini, de Souza Melo, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649438/
https://www.ncbi.nlm.nih.gov/pubmed/34823403
http://dx.doi.org/10.1177/00469580211060184
_version_ 1784610996468318208
author Sobral, Marcos Felipe Falcão
Bezerra de Oliveira, Brigitte Renata
Gomes da Penha Sobral, Ana Iza
Monteiro Marinho, Marcelo Luiz
Duarte, Gisleia Benini
de Souza Melo, André
author_facet Sobral, Marcos Felipe Falcão
Bezerra de Oliveira, Brigitte Renata
Gomes da Penha Sobral, Ana Iza
Monteiro Marinho, Marcelo Luiz
Duarte, Gisleia Benini
de Souza Melo, André
author_sort Sobral, Marcos Felipe Falcão
collection PubMed
description The present study aimed to identify the factors associated with the distribution of the first doses of the COVID-19 vaccine. In this study, we used 9 variables: human development index (HDI), gross domestic product (GDP per capita), Gini index, population density, extreme poverty, life expectancy, COVID cases, COVID deaths, and reproduction rate. The time period was until February 1, 2021. The variable of interest was the sum of the days after the vaccine arrived in the countries. Pearson’s correlation coefficients were calculated, and t-test was performed between the groups that received and did not receive the immunizer, and finally, a stepwise linear regression model was used. 58 (30.4%) of the 191 countries received the SARS-CoV-2 vaccine. The countries that received the most doses were the United States, China, the United Kingdom, and Israel. Vaccine access in days showed a positive Pearson correlation HDI, GDP, life expectancy, COVID-19 cases, deaths, and reproduction rate. Human development level, COVID-19 deaths, GDP per capita, and population density are able to explain almost 50% of the speed of access to immunizers. Countries with higher HDI and per capita income obtained priority access.
format Online
Article
Text
id pubmed-8649438
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-86494382021-12-08 SARS-COV-2 Vaccines: What Indicators are Associated with the Worldwide Distribution of the First Doses Sobral, Marcos Felipe Falcão Bezerra de Oliveira, Brigitte Renata Gomes da Penha Sobral, Ana Iza Monteiro Marinho, Marcelo Luiz Duarte, Gisleia Benini de Souza Melo, André Inquiry Original Research Article The present study aimed to identify the factors associated with the distribution of the first doses of the COVID-19 vaccine. In this study, we used 9 variables: human development index (HDI), gross domestic product (GDP per capita), Gini index, population density, extreme poverty, life expectancy, COVID cases, COVID deaths, and reproduction rate. The time period was until February 1, 2021. The variable of interest was the sum of the days after the vaccine arrived in the countries. Pearson’s correlation coefficients were calculated, and t-test was performed between the groups that received and did not receive the immunizer, and finally, a stepwise linear regression model was used. 58 (30.4%) of the 191 countries received the SARS-CoV-2 vaccine. The countries that received the most doses were the United States, China, the United Kingdom, and Israel. Vaccine access in days showed a positive Pearson correlation HDI, GDP, life expectancy, COVID-19 cases, deaths, and reproduction rate. Human development level, COVID-19 deaths, GDP per capita, and population density are able to explain almost 50% of the speed of access to immunizers. Countries with higher HDI and per capita income obtained priority access. SAGE Publications 2021-11-25 /pmc/articles/PMC8649438/ /pubmed/34823403 http://dx.doi.org/10.1177/00469580211060184 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Sobral, Marcos Felipe Falcão
Bezerra de Oliveira, Brigitte Renata
Gomes da Penha Sobral, Ana Iza
Monteiro Marinho, Marcelo Luiz
Duarte, Gisleia Benini
de Souza Melo, André
SARS-COV-2 Vaccines: What Indicators are Associated with the Worldwide Distribution of the First Doses
title SARS-COV-2 Vaccines: What Indicators are Associated with the Worldwide Distribution of the First Doses
title_full SARS-COV-2 Vaccines: What Indicators are Associated with the Worldwide Distribution of the First Doses
title_fullStr SARS-COV-2 Vaccines: What Indicators are Associated with the Worldwide Distribution of the First Doses
title_full_unstemmed SARS-COV-2 Vaccines: What Indicators are Associated with the Worldwide Distribution of the First Doses
title_short SARS-COV-2 Vaccines: What Indicators are Associated with the Worldwide Distribution of the First Doses
title_sort sars-cov-2 vaccines: what indicators are associated with the worldwide distribution of the first doses
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649438/
https://www.ncbi.nlm.nih.gov/pubmed/34823403
http://dx.doi.org/10.1177/00469580211060184
work_keys_str_mv AT sobralmarcosfelipefalcao sarscov2vaccineswhatindicatorsareassociatedwiththeworldwidedistributionofthefirstdoses
AT bezerradeoliveirabrigitterenata sarscov2vaccineswhatindicatorsareassociatedwiththeworldwidedistributionofthefirstdoses
AT gomesdapenhasobralanaiza sarscov2vaccineswhatindicatorsareassociatedwiththeworldwidedistributionofthefirstdoses
AT monteiromarinhomarceloluiz sarscov2vaccineswhatindicatorsareassociatedwiththeworldwidedistributionofthefirstdoses
AT duartegisleiabenini sarscov2vaccineswhatindicatorsareassociatedwiththeworldwidedistributionofthefirstdoses
AT desouzameloandre sarscov2vaccineswhatindicatorsareassociatedwiththeworldwidedistributionofthefirstdoses